473 related articles for article (PubMed ID: 30030966)
21. Exercise versus airway clearance techniques for people with cystic fibrosis.
Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
[TBL] [Abstract][Full Text] [Related]
22. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
[TBL] [Abstract][Full Text] [Related]
23. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
24. Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds.
Gurusamy KS; Koti R; Toon CD; Wilson P; Davidson BR
Cochrane Database Syst Rev; 2013 Nov; (11):CD010427. PubMed ID: 24242704
[TBL] [Abstract][Full Text] [Related]
25. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Aslam AA; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012040. PubMed ID: 36866921
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Jeffery TC; Chang AB; Conwell LS
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD002010. PubMed ID: 36625789
[TBL] [Abstract][Full Text] [Related]
27. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD009530. PubMed ID: 30221745
[TBL] [Abstract][Full Text] [Related]
28. Probiotics for people with cystic fibrosis.
Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
[TBL] [Abstract][Full Text] [Related]
29. Appetite stimulants for people with cystic fibrosis.
McTavish D; Thornton J
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD008190. PubMed ID: 36149378
[TBL] [Abstract][Full Text] [Related]
30. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
Yotsu RR; Richardson M; Ishii N
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012118. PubMed ID: 30136733
[TBL] [Abstract][Full Text] [Related]
31. Non-invasive ventilation for cystic fibrosis.
Moran F; Bradley JM; Piper AJ
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002769. PubMed ID: 28218802
[TBL] [Abstract][Full Text] [Related]
32. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
33. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2016 Jan; (1):CD009530. PubMed ID: 26797965
[TBL] [Abstract][Full Text] [Related]
34. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
Lands LC; Stanojevic S
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD001505. PubMed ID: 31499593
[TBL] [Abstract][Full Text] [Related]
35. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Smith S; Lykkesfeldt J
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
[TBL] [Abstract][Full Text] [Related]
36. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of a methicillin-resistant Staphylococcus aureus (MRSA) eradication protocol in pediatric cystic fibrosis (CF) patients.
Belarski E; Pettit R
Pediatr Pulmonol; 2020 Mar; 55(3):654-659. PubMed ID: 31899860
[TBL] [Abstract][Full Text] [Related]
38. Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.
Jones M; Moffatt F; Harvey A; Ryan JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013610. PubMed ID: 37462324
[TBL] [Abstract][Full Text] [Related]
39. Dornase alfa for cystic fibrosis.
Yang C; Montgomery M
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
[TBL] [Abstract][Full Text] [Related]
40. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]